Mosaic ImmunoEngineering (CPMV) Non-Current Assets (2011 - 2020)
Mosaic ImmunoEngineering (CPMV) posted quarterly Non-Current Assets of $34851.0 for Q1 2020, down 81.57% year-over-year from $189055.0 in Q1 2019, and down 0.74% quarter-over-quarter from $35112.0 in Q4 2019.
Mosaic ImmunoEngineering (CPMV) Non-Current Assets (2011 - 2020) Analysis & Trends
Mosaic ImmunoEngineering's Non-Current Assets history runs 10 years deep, the most recent figure standing at $34851.0 for Q1 2020.
- In Q1 2020, Non-Current Assets fell 81.57% year-over-year to $34851.0; the TTM figure through Nov 2020 stood at $34851.0 (down 92.67% YoY), while the FY2019 annual figure was $134753.0, down 46.7% from the prior year.
- Non-Current Assets for Q1 2020 stood at $34851.0, down from $35112.0 in the prior quarter.
- The five-year high for Non-Current Assets was $981379.0 in Q4 2016, with the low at $34851.0 in Q1 2020.
- The 5-year median for Non-Current Assets is $325523.0 (2017), against an average of $370313.6.
- The sharpest annual moves came in 2016 and 2019: Non-Current Assets jumped 12149.2% in 2016, then sank 84.26% in 2019.
- Mosaic ImmunoEngineering's Non-Current Assets stood at $981379.0 in 2016, then sank by 66.83% to $325523.0 in 2017, then slumped by 31.47% to $223065.0 in 2018, then tumbled by 84.26% to $35112.0 in 2019, then retreated by 0.74% to $34851.0 in 2020.
- Business Quant data shows CPMV's Non-Current Assets at $34851.0 in Q1 2020, $35112.0 in Q4 2019, and $116397.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 18.06 Bn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 29, 2020 | 34,851.00 |
| Nov 30, 2019 | 35,112.00 |
| Aug 31, 2019 | 116,397.00 |
| May 31, 2019 | 134,753.00 |
| Feb 28, 2019 | 189,055.00 |
| Nov 30, 2018 | 223,065.00 |
| Aug 31, 2018 | 237,930.00 |
| May 31, 2018 | 252,832.00 |
| Feb 28, 2018 | 332,935.00 |
| Nov 30, 2017 | 325,523.00 |
| Aug 31, 2017 | 430,438.00 |
| May 31, 2017 | 443,865.00 |
| Feb 28, 2017 | 699,188.00 |
| Nov 30, 2016 | 981,379.00 |
| Aug 31, 2016 | 618,711.00 |
| May 31, 2016 | 670,766.00 |
| Feb 29, 2016 | 568,531.00 |
| Nov 30, 2015 | 702,048.00 |
| Aug 31, 2015 | 241,916.00 |
| May 31, 2015 | 5,476.00 |